Works by Lub-de Hooge, Marjolijn N.


Results: 76
    1
    2
    3

    PET/CT Imaging of 89Zr-N-sucDf-Pembrolizumab in Healthy Cynomolgus Monkeys.

    Published in:
    Molecular Imaging & Biology, 2021, v. 23, n. 2, p. 250, doi. 10.1007/s11307-020-01558-w
    By:
    • Li, Wenping;
    • Wang, Yuchuan;
    • Rubins, Daniel;
    • Bennacef, Idriss;
    • Holahan, Marie;
    • Haley, Hyking;
    • Purcell, Mona;
    • Gantert, Liza;
    • Hseih, SuChun;
    • Judo, Michael;
    • Seghezzi, Wolfgang;
    • Zhang, Shuli;
    • van der Veen, Elly L.;
    • Lub-de Hooge, Marjolijn N.;
    • de Vries, Elisabeth G.E.;
    • Evelhoch, Jeffrey L.;
    • Klimas, Michael;
    • Hostetler, Eric D.
    Publication type:
    Article
    4
    5

    Preclinical characterisation of 111In-DTPA-trastuzumab.

    Published in:
    British Journal of Pharmacology, 2004, v. 143, n. 1, p. 99, doi. 10.1038/sj.bjp.0705915
    By:
    • Lub-de Hooge, Marjolijn N.;
    • Kosterink, Jos G.W.;
    • Perik, Patrick J.;
    • Nijnuis, Hugo;
    • Tran, Ly;
    • Bart, Joost;
    • Suurmeijer, Albert J.H.;
    • de Jong, Steven;
    • Jager, Pieter L.;
    • de Vries, Elisabeth G.E.
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15

    Molecular Imaging in Cancer Drug Development.

    Published in:
    Journal of Nuclear Medicine, 2018, v. 59, n. 5, p. 726, doi. 10.2967/jnumed.116.188045
    By:
    • Waaijer, Stijn J. H.;
    • Kok, Iris C.;
    • Eisses, Bertha;
    • Schröder, Carolina P.;
    • Jalving, Mathilde;
    • Brouwers, Adrienne H.;
    • Lub-de Hooge, Marjolijn N.;
    • de Vries, Elisabeth G. E.
    Publication type:
    Article
    16

    Theranostics Using Antibodies and Antibody-Related Therapeutics.

    Published in:
    Journal of Nuclear Medicine, 2017, v. 58, p. 83S, doi. 10.2967/jnumed.116.186940
    By:
    • Moek, Kirsten L.;
    • Giesen, Danique;
    • Kok, Iris C.;
    • de Groot, Derk Jan A.;
    • Jalving, Mathilde;
    • Fehrmann, Rudolf S. N.;
    • Lub-de Hooge, Marjolijn N.;
    • Brouwers, Adrienne H.;
    • de Vries, Elisabeth G. E.
    Publication type:
    Article
    17
    18
    19

    <sup>89</sup>Zr-Bevacizumab PET Visualizes Disease Manifestations in Patients with von Hippel-Lindau Disease.

    Published in:
    Journal of Nuclear Medicine, 2016, v. 57, n. 8, p. 1244, doi. 10.2967/jnumed.115.167643
    By:
    • Oosting, Sjoukje F.;
    • van Asselt, Sophie J.;
    • Brouwers, Adrienne H.;
    • Bongaerts, Alfons H.H.;
    • Steinberg, Julia D.J.;
    • de Jong, Johan R.;
    • Lub-de Hooge, Marjolijn N.;
    • van der Horst-Schrivers, Anouk N.A.;
    • Walenkamp, Annemiek M.E.;
    • Hoving, Eelco W.;
    • Sluiter, Wim J.;
    • Zonnenberg, Bernard A.;
    • de Vries, Elisabeth G.E.;
    • Links, Thera P.
    Publication type:
    Article
    20
    21
    22

    TGF-β Antibody Uptake in Recurrent High-Grade Glioma Imaged with <sup>89</sup>Zr-Fresolimumab PET.

    Published in:
    Journal of Nuclear Medicine, 2015, v. 56, n. 9, p. 1310, doi. 10.2967/jnumed.115.154401
    By:
    • den Hollander, Martha W.;
    • Bensch, Frederike;
    • Glaudemans, Andor W. J. M.;
    • Munnink, Thijs H. Oude;
    • Enting, Roelien H.;
    • den Dunnen, Wilfred F. A.;
    • Heesters, Mart A. A. M.;
    • Kruyt, Frank A. E.;
    • Lub-de Hooge, Marjolijn N.;
    • de Groot, Jan Cees;
    • Pearlberg, Joseph;
    • Gietema, Jourik A.;
    • de Vries, Elisabeth G. E.;
    • Walenkamp, Annemiek M. E.
    Publication type:
    Article
    23

    <sup>89</sup>Zr-Bevacizumab PET Visualizes Heterogeneous Tracer Accumulation in Tumor Lesions of Renal Cell Carcinoma Patients and Differential Effects of Antiangiogenic Treatment.

    Published in:
    Journal of Nuclear Medicine, 2015, v. 56, n. 1, p. 63, doi. 10.2967/jnumed.114.144840
    By:
    • Oosting, Sjoukje F.;
    • Brouwers, Adrienne H.;
    • van Es, Suzanne C.;
    • Nagengast, Wouter B.;
    • Munnink, Thijs H. Oude;
    • Lub-de Hooge, Marjolijn N.;
    • Hollema, Harry;
    • de Jong, Johan R.;
    • de Jong, Igle J.;
    • de Haas, Sanne;
    • Scherer, Stefan J.;
    • Sluiter, Wim J.;
    • Dierckx, Rudi A.;
    • Bongaerts, Alfons H. H.;
    • Gietema, Jourik A.;
    • de Vries, Elisabeth G. E.
    Publication type:
    Article
    24
    25

    In Vivo Visualization of MET Tumor Expression and Anticalin Biodistribution with the MET-Specific Anticalin <sup>89</sup>Zr-PRS-110 PET Tracer.

    Published in:
    Journal of Nuclear Medicine, 2014, v. 55, n. 4, p. 665, doi. 10.2967/jnumed.113.124941
    By:
    • Terwisscha van Scheltinga, Anton G. T.;
    • Lub-de Hooge, Marjolijn N.;
    • Hinner, Marlon J.;
    • Verheijenj, Remy B.;
    • Allersdorfer, Andrea;
    • Hülsmeyer, Martin;
    • Nagengast, Wouter B.;
    • Schröder, Carolien P.;
    • Kosterink, Jos G. W.;
    • de Vries, Elisabeth G. E.;
    • Audoly, Laurent;
    • Olwill, Shane A.
    Publication type:
    Article
    26
    27
    28

    <sup>89</sup>Zr-Bevacizumab PET of Early Antiangiogenic Tumor Response to Treatment with HSP90 Inhibitor NVP-AUY922.

    Published in:
    Journal of Nuclear Medicine, 2010, v. 51, n. 5, p. 761, doi. 10.2967/jnumed.109.071043
    By:
    • Nagengast, Wouter B.;
    • de Korte, Maarten A.;
    • Munnink, Thijs H. Oude;
    • Timmer-Bosscha, Hetty;
    • den Dunnen, Wifred F.;
    • Hollema, Harry;
    • de Jong, Johan R.;
    • Jensen, Michael R.;
    • Quadt, Cornelia;
    • Garcia-Echeverria, Carlos;
    • van Dongen, Guus A. M. S.;
    • Hooge, Marjolijn N. Lub-de;
    • Schröder, Carolien P.;
    • de Vries, Elisabeth G. E.
    Publication type:
    Article
    29
    30
    31
    32
    33

    Advances and challenges in immunoPET methodology.

    Published in:
    Frontiers in Nuclear Medicine, 2024, p. 01, doi. 10.3389/fnume.2024.1360710
    By:
    • Mohr, Philipp;
    • van Sluis, Joyce;
    • Lub-de Hooge, Marjolijn N.;
    • Lammertsma, Adriaan A.;
    • Brouwers, Adrienne H.;
    • Tsoumpas, Charalampos
    Publication type:
    Article
    34

    Advances and challenges in immunoPET methodology.

    Published in:
    Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360710
    By:
    • Mohr, Philipp;
    • van Sluis, Joyce;
    • Lub-de Hooge, Marjolijn N.;
    • Lammertsma, Adriaan A.;
    • Brouwers, Adrienne H.;
    • Tsoumpas, Charalampos
    Publication type:
    Article
    35

    Advances and challenges in immunoPET methodology.

    Published in:
    Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360710
    By:
    • Mohr, Philipp;
    • van Sluis, Joyce;
    • Hooge, Marjolijn N. Lub-de;
    • Lammertsma, Adriaan A.;
    • Brouwers, Adrienne H.;
    • Tsoumpas, Charalampos
    Publication type:
    Article
    36

    Advances and challenges in immunoPET methodology.

    Published in:
    Frontiers in Nuclear Medicine, 2024, p. 1, doi. 10.3389/fnume.2024.1360710
    By:
    • Mohr, Philipp;
    • van Sluis, Joyce;
    • Hooge, Marjolijn N. Lub-de;
    • Lammertsma, Adriaan A.;
    • Brouwers, Adrienne H.;
    • Tsoumpas, Charalampos
    Publication type:
    Article
    37
    38
    39
    40

    Whole-Body HER2 Heterogeneity Identified on HER2 PET in HER2-Negative, -Low, and -Positive Metastatic Breast Cancer.

    Published in:
    Journal of Nuclear Medicine, 2024, v. 65, n. 10, p. 1540, doi. 10.2967/jnumed.124.267636
    By:
    • Eisses, Bertha;
    • van Geel, Jasper J.L.;
    • Brouwers, Adrienne H.;
    • Bensch, Frederike;
    • Elias, Sjoerd G.;
    • Kuip, Evelien J.M.;
    • Jager, Agnes;
    • van der Vegt, Bert;
    • Lub-de Hooge, Marjolijn N.;
    • Emmering, Jasper;
    • Arens, Anne I.J.;
    • Zwezerijnen, Gerben J.C.;
    • Vugts, Daniëlle J.;
    • Menke-van der Houven van Oordt, C. Willemien;
    • de Vries, Elisabeth G.E.;
    • Schröder, Carolina P.;
    • Bensch, F.;
    • van Es, S.;
    • van Essen-Eisses, B.;
    • Boers, J.
    Publication type:
    Article
    41
    42

    <sup>89</sup>Zr-3,2-HOPO-Mesothelin Antibody PET Imaging Reflects Tumor Uptake of Mesothelin-Targeted <sup>227</sup>Th-Conjugate Therapy in Mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1715, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    43

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans Valentijn;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    44

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    45

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 7, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    46

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging 1 reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    47

    <sup>89</sup>Zr-3,2-HOPO-mesothelin antibody PET imaging reflects tumor uptake of mesothelin targeted <sup>227</sup>Th-conjugate therapy in mice.

    Published in:
    Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263079
    By:
    • Broer, Linda N.;
    • Knapen, Daan G.;
    • Suurs, Frans V.;
    • Moen, Ingrid;
    • Giesen, Danique;
    • Waaijer, Stijn J. H.;
    • Indrevoll, Baard;
    • Ellingsen, Christine;
    • Kristian, Alexander;
    • Cuthbertson, Alan S.;
    • de Groot, Derk-Jan A.;
    • Cole, Patricia E.;
    • de Vries, Elisabeth G. E.;
    • Hagemann, Urs B.;
    • Lub-de Hooge, Marjolijn N.
    Publication type:
    Article
    48
    49
    50